Subtle Medical Awarded Breakthrough Patent for Reduced Contrast Agent Dosage in Medical Imaging Exams
Subtle s AI-powered SubtleGAD™ Software Improves Patient Safety by Enabling a 90% Dose Reduction in Contrast-Enhanced MRI
News provided by
Share this article
Share this article
MENLO PARK, Calif., May 4, 2021 /PRNewswire/ Subtle Medical, Inc., a leading healthcare technology company using artificial intelligence (AI) to improve the speed and quality of medical imaging, announced the issuance of U.S. Patent No. 10,997,716 for their licensed innovative software that uses deep learning to drastically reduce contrast dosage needed during contrast-enhanced medical imaging exams. The patent was invented by Drs. Greg Zaharchuk and Enhao Gong prior to co-founding Subtle Medical and is based on technology exclusively licensed from Stanford University. This marks another milestone in Subtle s mission to accelerate universal access to faster, safer, and smarter medical imaging.
Share this article
Share this article
MENLO PARK, Calif., March 10, 2021 /PRNewswire/ Subtle Medical, a healthcare technology company revolutionizing the radiology industry by improving the quality and efficiency of medical imaging, announced today 510(k) clearance from the U.S. Food and Drug Administration (FDA) for the second generation of their SubtleMR™ image enhancement technology. The vendor-neutral software is a virtual upgrade to existing MRI machines that can boost scanner performance across the entire fleet.
SubtleMR™ is an image processing software that can be used for the enhancement of MRI images. It can now be used to reduce image noise for the entire body, including but not limited to, head, spine, neck, abdomen, pelvis, prostate, breast and musculoskeletal regions of the body, and increase image sharpness for head MRI.